Almasri E - Search Results

1

Positive cfDNA screening results for 22q11.2 deletion syndrome-Clinical and laboratory considerations.

Soster E, Dyr B, Rafalko J, Almasri E, Cacheris P. Soster E, et al. Among authors: almasri e. Front Genet. 2023 Mar 10;14:1146669. doi: 10.3389/fgene.2023.1146669. eCollection 2023. Front Genet. 2023. PMID: 36968594 Free PMC article.

2

A new era in aneuploidy screening: cfDNA testing in >30,000 multifetal gestations: Experience at one clinical laboratory.

Dyr B, Boomer T, Almasri EA, Wardrop JL, Rafalko J, Chibuk J, McCullough RM. Dyr B, et al. PLoS One. 2019 Aug 8;14(8):e0220979. doi: 10.1371/journal.pone.0220979. eCollection 2019. PLoS One. 2019. PMID: 31393959 Free PMC article.

3

Cell-free DNA screening in twin pregnancies: A more accurate and reliable screening tool.

Chibuk J, Rafalko J, Boomer T, McCullough R, McLennan G, Wyatt P, Almasri E. Chibuk J, et al. Among authors: almasri e. Prenat Diagn. 2020 Sep;40(10):1321-1329. doi: 10.1002/pd.5797. Epub 2020 Jul 28. Prenat Diagn. 2020. PMID: 32677048 Free PMC article.

4

Impact of mosaicism ratio on positive predictive value of cfDNA screening.

Rafalko JM, Caldwell S, Tynan J, Almasri E, Weinblatt V, McCullough R. Rafalko JM, et al. Among authors: almasri e. Prenat Diagn. 2021 Jan;41(1):28-34. doi: 10.1002/pd.5863. Epub 2020 Nov 25. Prenat Diagn. 2021. PMID: 33151555 Free PMC article.

5

Not all low fetal fraction cell-free DNA screening failures are at increased risk for aneuploidy.

Caldwell S, Almasri E, Schmidt L, Xu C, Dyr B, Wardrop J, Cacheris P. Caldwell S, et al. Among authors: almasri e. Prenat Diagn. 2021 Oct;41(11):1372-1379. doi: 10.1002/pd.5918. Epub 2021 Mar 8. Prenat Diagn. 2021. PMID: 33682142 Free PMC article.

6

Application of mosaicism ratio to multifetal gestations.

Rafalko J, Caldwell S, Soster E, Almasri E, McLennan G, Liu T, Weinblatt V, Cacheris P, McCullough R. Rafalko J, et al. Among authors: almasri e. PLoS One. 2021 Mar 12;16(3):e0248467. doi: 10.1371/journal.pone.0248467. eCollection 2021. PLoS One. 2021. PMID: 33711042 Free PMC article. Clinical Trial.

7

Three years of clinical experience with a genome-wide cfDNA screening test for aneuploidies and copy-number variants.

Soster E, Boomer T, Hicks S, Caldwell S, Dyr B, Chibuk J, Almasri E. Soster E, et al. Among authors: almasri e. Genet Med. 2021 Jul;23(7):1349-1355. doi: 10.1038/s41436-021-01135-8. Epub 2021 Mar 17. Genet Med. 2021. PMID: 33731879 Free PMC article.

8

Correction to: Three years of clinical experience with a genome-wide cfDNA screening test for aneuploidies and copy number variants.

Soster E, Boomer T, Hicks S, Caldwell S, Dyr B, Chibuk J, Almasri E. Soster E, et al. Among authors: almasri e. Genet Med. 2021 Jul;23(7):1378. doi: 10.1038/s41436-021-01190-1. Genet Med. 2021. PMID: 33958750 Free PMC article. No abstract available.

9

Genome-wide cell-free DNA screening: a focus on copy-number variants.

Rafalko J, Soster E, Caldwell S, Almasri E, Westover T, Weinblatt V, Cacheris P. Rafalko J, et al. Among authors: almasri e. Genet Med. 2021 Oct;23(10):1847-1853. doi: 10.1038/s41436-021-01227-5. Epub 2021 Jun 21. Genet Med. 2021. PMID: 34155363 Free PMC article.

10

Laboratory performance of genome-wide cfDNA for copy number variants as compared to prenatal microarray.

Soster E, Tynan J, Gibbons C, Meschino W, Wardrop J, Almasri E, Schwartz S, McLennan G. Soster E, et al. Among authors: almasri e. Mol Cytogenet. 2023 Jun 10;16(1):10. doi: 10.1186/s13039-023-00642-4. Mol Cytogenet. 2023. PMID: 37301962 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50 results

Search Page

Filters